AU774068B2 - Vectors and methods for recombinant protein expression - Google Patents

Vectors and methods for recombinant protein expression

Info

Publication number
AU774068B2
AU774068B2 AU80216/00A AU8021600A AU774068B2 AU 774068 B2 AU774068 B2 AU 774068B2 AU 80216/00 A AU80216/00 A AU 80216/00A AU 8021600 A AU8021600 A AU 8021600A AU 774068 B2 AU774068 B2 AU 774068B2
Authority
AU
Australia
Prior art keywords
protein
expression vector
expression
polyadenylation site
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU80216/00A
Other languages
English (en)
Other versions
AU8021600A (en
Inventor
Jeffrey T. Mcgrew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22571409&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU774068(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of AU8021600A publication Critical patent/AU8021600A/en
Application granted granted Critical
Publication of AU774068B2 publication Critical patent/AU774068B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU80216/00A 1999-10-13 2000-10-12 Vectors and methods for recombinant protein expression Ceased AU774068B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15917799P 1999-10-13 1999-10-13
US60/159177 1999-10-13
PCT/US2000/028431 WO2001027299A1 (en) 1999-10-13 2000-10-12 Vectors and methods for recombinant protein expression

Publications (2)

Publication Number Publication Date
AU8021600A AU8021600A (en) 2001-04-23
AU774068B2 true AU774068B2 (en) 2004-06-17

Family

ID=22571409

Family Applications (1)

Application Number Title Priority Date Filing Date
AU80216/00A Ceased AU774068B2 (en) 1999-10-13 2000-10-12 Vectors and methods for recombinant protein expression

Country Status (13)

Country Link
US (2) US6632637B1 (cg-RX-API-DMAC7.html)
EP (1) EP1222298B1 (cg-RX-API-DMAC7.html)
JP (1) JP4660046B2 (cg-RX-API-DMAC7.html)
AT (1) ATE312186T1 (cg-RX-API-DMAC7.html)
AU (1) AU774068B2 (cg-RX-API-DMAC7.html)
CA (1) CA2386180C (cg-RX-API-DMAC7.html)
CY (1) CY1105336T1 (cg-RX-API-DMAC7.html)
DE (1) DE60024659T2 (cg-RX-API-DMAC7.html)
DK (1) DK1222298T3 (cg-RX-API-DMAC7.html)
ES (1) ES2252070T3 (cg-RX-API-DMAC7.html)
IL (2) IL148785A0 (cg-RX-API-DMAC7.html)
NZ (1) NZ518388A (cg-RX-API-DMAC7.html)
WO (1) WO2001027299A1 (cg-RX-API-DMAC7.html)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050005310A1 (en) * 1999-07-12 2005-01-06 Genentech, Inc. Expression vectors and methods
DK1222298T3 (da) * 1999-10-13 2006-04-10 Immunex Corp Vektorer og fremgangsmåder til rekombinant proteinekspression
US7691605B2 (en) 2001-09-20 2010-04-06 Immunex Corporation Selection of cells expressing heteromeric polypeptides
US20030157641A1 (en) * 2001-11-16 2003-08-21 Idec Pharmaceuticals Corporation Polycistronic expression of antibodies
ES2557741T3 (es) 2002-03-27 2016-01-28 Immunex Corporation Procedimientos para incrementar la producción de polipéptidos
US20050019925A1 (en) * 2002-11-14 2005-01-27 Genentech, Inc. Intron fusion construct and method of using for selecting high-expressing production cell lines
KR100533794B1 (ko) * 2003-10-02 2005-12-07 주식회사 프로젠 인간 난포자극 호르몬을 대량으로 생산하는 방법
WO2005123915A1 (en) 2004-06-21 2005-12-29 Novozymes A/S Stably maintained multiple copies of at least two orf in the same orientation
WO2006012414A2 (en) * 2004-07-20 2006-02-02 Critical Therapeutics, Inc. Novel polyadenylation signal for use in expression vectors
WO2006093053A1 (ja) * 2005-03-02 2006-09-08 Astellas Pharma Inc. ヒストンデアセチラーゼ阻害剤の新規pdマーカー
CN101595228A (zh) 2005-07-21 2009-12-02 艾博特公司 包括sorf构建体的多基因表达和使用多蛋白、前体蛋白和蛋白酶解的方法
TW201516149A (zh) 2006-09-13 2015-05-01 Abbvie Inc 細胞培養改良
EP2500416A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
JP2011512877A (ja) * 2008-03-12 2011-04-28 ワイス・エルエルシー 組換えタンパク質の大スケール産生に適した細胞を同定する方法
CN102365364B (zh) 2009-03-31 2015-01-21 株式会社斯特利恩 用于选择高效表达重组细胞系的方法
JP2013509188A (ja) * 2009-10-30 2013-03-14 アボット・ラボラトリーズ Sorf構築物および複数の遺伝子発現
WO2011113841A1 (en) * 2010-03-16 2011-09-22 Robert Steinfeld Eukaryotic vector
CN103391998A (zh) * 2010-07-26 2013-11-13 Adv生物制剂公司 用于重组蛋白表达的载体和方法
JP5913122B2 (ja) * 2010-11-08 2016-04-27 Jcrファーマ株式会社 新規発現ベクター
IL210093A0 (en) * 2010-12-19 2011-06-30 David Helman Membrane bound reporter molecules and their use in cell sorting
AU2014237167B2 (en) 2013-03-15 2018-07-12 BASF Agricultural Solutions Seed US LLC Constitutive soybean promoters
US10227394B2 (en) 2014-04-08 2019-03-12 University Of Southern California Polypeptide compositions with type VII collagen fibronectin type III-like repeats and treatment methods for wound closure and healing
CN107043773B (zh) * 2017-02-08 2018-09-18 四川丰讯科技发展有限公司 一种提高哺乳动物细胞中外源基因表达水平的基因片段、重组载体及其用途
WO2020092448A1 (en) 2018-10-29 2020-05-07 Spin Therapeutics, Llc Compositions and methods for alpha-1-antitrypsin disorders
KR102490457B1 (ko) * 2019-11-26 2023-01-19 한국생명공학연구원 단백질 발현용 mRNA 구조체 및 이의 용도
EP4267717A1 (en) 2020-12-22 2023-11-01 Amgen Inc. Cell culture method

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965196A (en) * 1983-01-19 1990-10-23 Genentech, Inc. Polycistronic expression vector construction
US4937190A (en) * 1987-10-15 1990-06-26 Wisconsin Alumni Research Foundation Translation enhancer
AU644352B2 (en) * 1988-12-08 1993-12-09 Damon Biotech Inc. Expression induction method employing mutant dhfr gene
DE69333914T2 (de) * 1992-09-28 2006-08-10 Chiron Corp., Emeryville Verfahren und zusammensetzungen zur kontrolle der übersetzung der hcv-proteine
US5698446A (en) * 1994-09-07 1997-12-16 Chiron Corporation Methods and compositions for inhibiting production of replication competent virus
DE19514310A1 (de) 1995-04-18 1996-10-24 Univ Ludwigs Albert Vektoren zur Transfektion von eukaryotischen Zellen, deren Verwendung und damit transfizierte Zielzellen
GB9517263D0 (en) 1995-08-23 1995-10-25 Cancer Res Campaign Tech Expression systems
NZ330926A (en) 1996-01-11 1999-11-29 Immunex Corp Expression augmenting sequence elements (ease) for eukaryotic expression systems
WO1998017689A2 (en) * 1996-10-18 1998-04-30 Valentis Inc. Il-12 gene expression and delivery systems and uses
DK1222298T3 (da) * 1999-10-13 2006-04-10 Immunex Corp Vektorer og fremgangsmåder til rekombinant proteinekspression

Also Published As

Publication number Publication date
DK1222298T3 (da) 2006-04-10
EP1222298A1 (en) 2002-07-17
IL148785A (en) 2007-09-20
ATE312186T1 (de) 2005-12-15
DE60024659D1 (de) 2006-01-12
US6632637B1 (en) 2003-10-14
AU8021600A (en) 2001-04-23
WO2001027299A1 (en) 2001-04-19
NZ518388A (en) 2003-10-31
EP1222298B1 (en) 2005-12-07
US20040063186A1 (en) 2004-04-01
CY1105336T1 (el) 2010-03-03
ES2252070T3 (es) 2006-05-16
IL148785A0 (en) 2002-09-12
DE60024659T2 (de) 2006-08-17
CA2386180A1 (en) 2001-04-19
CA2386180C (en) 2010-03-09
JP4660046B2 (ja) 2011-03-30
JP2003511079A (ja) 2003-03-25

Similar Documents

Publication Publication Date Title
EP1222298B1 (en) Vectors and methods for recombinant protein expression
EP0770136B1 (en) Method for selecting high-expressing host cells
EP0873405B1 (en) Expression augmenting sequence elements (ease) for eukaryotic expression systems
US5043270A (en) Intronic overexpression vectors
CN101687910A (zh) 具有高效分泌信号序列的哺乳动物表达载体
JP4817514B2 (ja) 新規動物細胞用ベクターおよびその使用
WO2008121324A2 (en) Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells
AU1835600A (en) Methods for making recombinant cells
US9260721B2 (en) Expression vector and methods of producing high levels of proteins
US20050019925A1 (en) Intron fusion construct and method of using for selecting high-expressing production cell lines
JP2008536506A (ja) mCMVプロモーターおよびhCMV主要最初期遺伝子を含む哺乳類発現ベクター
US5747308A (en) Recombinant DNA method
JP2005511031A (ja) ヘテロマーポリペプチドを発現する細胞の選択
US20190309323A1 (en) Promoter with an enriched cytosine-guanine dinucleotide region, vectors, cellular lines, method for producing recombinant protein
AU8021600B2 (cg-RX-API-DMAC7.html)
EP3146057B1 (en) Method for production of polypeptides
HK1112020B (en) Expression vector and methods of producing high levels of proteins

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)